Dual targeting of MDM2 and BCL2 as a therapeutic strategy in neuroblastoma.

Dual targeting of MDM2 and BCL2 as a therapeutic strategy in neuroblastoma. Oncotarget. 2017 Aug 22; 8(34):57047-57057.

View in: PubMed